ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Stryker Corp

Stryker Corp (SYK)

328.56
-10.81
(-3.19%)
Closed July 15 4:00PM
328.56
0.00
( 0.00% )
Pre Market: 4:00AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
328.56
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
249.98 52 Week Range 361.41
Market Cap
Previous Close
328.56
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
1,270,533
Shares Outstanding
380,949,778
Dividend Yield
0.96%
PE Ratio
39.55
Earnings Per Share (EPS)
8.31
Revenue
20.5B
Net Profit
3.17B

About Stryker Corp

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. St... Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Nearly one fourth of Stryker's total revenue currently comes from outside the United States. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
Headquarters
Plymouth, Michigan, USA
Founded
1970
Stryker Corp is listed in the Surgical,med Instr,apparatus sector of the New York Stock Exchange with ticker SYK. The last closing price for Stryker was $328.56. Over the last year, Stryker shares have traded in a share price range of $ 249.98 to $ 361.41.

Stryker currently has 380,949,778 shares outstanding. The market capitalization of Stryker is $125.16 billion. Stryker has a price to earnings ratio (PE ratio) of 39.55.

Stryker (SYK) Options Flow Summary

Overall Flow

Bullish

Net Premium

143k

Calls / Puts

200.00%

Buys / Sells

50.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

SYK Latest News

Stryker Completes Acquisition of Artelon, Inc.

Stryker (NYSE: SYK), a global leader in medical technologies, has completed the previously announced acquisition of Artelon, a privately held company specializing in innovative soft tissue...

Stryker to announce financial results for its second quarter of fiscal year 2024

Portage, Michigan, July 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2024 on Tuesday, July 30, 2024.  A press...

Stryker joins Atrium Health affiliate IRCAD North America to advance surgical training and education

Stryker joins Atrium Health affiliate IRCAD North America to advance surgical training and education PR Newswire PORTAGE, Michigan and CHARLOTTE, North Carolina, USA, June 18, 2024 PORTAGE...

Stryker releases LIFEPAK 35 monitor/defibrillator

Stryker releases LIFEPAK 35 monitor/defibrillator PR Newswire PORTAGE, Mich., USA, June 4, 2024 LIFEPAK 35, a clinically advanced monitor/defibrillator, reduces caregiver burden and streamlines...

Stryker Announces Definitive Agreement to Acquire Artelon, Inc., Offering a Range of Soft Tissue Fixation Solutions for Orthopaedic Surgeons

Stryker (NYSE: SYK), a global leader in medical technologies, announced the signing of a definitive agreement to acquire all of the issued and outstanding shares of Artelon, a privately held...

Die ersten Operationen in Europa mit dem Gamma4-Hüftfraktur-Nagelsystem von Stryker wurden erfolgreich abgeschlossen

Das Gamma4-System wird nach über 35 erfolgreichen Operationen in Deutschland im Rahmen einer Live-Übertragung auf den Markt gebracht Stryker (NYSE:SYK), ein Weltmarktführer im Bereich...

First European Surgeries Completed Using Stryker’s Gamma4 Hip Fracture Nailing System

With over 35 successful surgeries, the Gamma4 system will be launched in live broadcast event in Germany Stryker (NYSE:SYK), a global leader in medical technologies, announced that the first...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-6.72-2.00429491768335.28340.99327.82914136334.92629161CS
4-16.44-4.7652173913345349327.82968301338.353284CS
120.009999999999990.00304367676153328.55351.5605320.7151270533336.21871302CS
2616.195.18295610974312.37361.41307.231279134338.36033007CS
5227.058.971510066301.51361.41249.981365757308.14614617CS
15671.5527.8393836816257.01361.41188.841358398269.76261148CS
260122.2959.2863722306206.27361.41124.541375286244.21077136CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CDTConduit Pharmaceuticals Inc
$ 0.49205
(105.02%)
11.51M
WNWMeiwu Technology Company Ltd
$ 1.24
(39.33%)
1.3M
SYRASyra Health Corporation
$ 1.75
(31.09%)
1
VSMEVS Media Holdings Ltd
$ 2.16
(22.73%)
454.43k
PASGPassage Bio Inc
$ 1.08
(17.23%)
12
GRNQGreenpro Capital Corporation
$ 0.9384
(-20.47%)
47.52k
AREBAmerican Rebel Holdings Inc
$ 0.5502
(-18.25%)
61.4k
AMIXAutonomix Medical Inc
$ 1.15
(-16.67%)
238.37k
CYNCYNGN Inc
$ 7.65
(-16.67%)
5.91k
DATSDatChat Inc
$ 1.61
(-14.81%)
70.26k
CDTConduit Pharmaceuticals Inc
$ 0.483
(101.25%)
11.23M
SLNASelina Hospitality PLC
$ 0.0716
(14.38%)
1.51M
WNWMeiwu Technology Company Ltd
$ 1.26
(41.57%)
1.29M
CGBSCrown LNG Holdings Ltd
$ 3.49
(10.79%)
688.32k
MAXNMaxeon Solar Technologies Ltd
$ 0.2215
(-2.42%)
609.65k

SYK Discussion

View Posts
LORTAP KCOTS LORTAP KCOTS 3 months ago
I’ll start setting my buys for $292.00, hopefully it does the classic retrace after earnings
👍️0
Monksdream Monksdream 3 months ago
SYK 10Q due 4/30
👍️0
Monksdream Monksdream 4 months ago
SYK new 52 week hi
👍️0
LORTAP KCOTS LORTAP KCOTS 5 months ago
Crazy
👍️0
Monksdream Monksdream 5 months ago
SYK new 52 week high
👍️0
LORTAP KCOTS LORTAP KCOTS 5 months ago
Crazy especially because there are a ton of insiders selling.
My buy back in price is at $270 now.
Might be a while before this goes back down 20%, but historically it will at some point..
👍️0
Monksdream Monksdream 5 months ago
SYK new 52 week high
👍️0
LORTAP KCOTS LORTAP KCOTS 5 months ago
New 52!!
Reload at 270 when the new higher low happens.
👍️0
LORTAP KCOTS LORTAP KCOTS 6 months ago
Love to see it consistently do it’s magic
👍️0
Monksdream Monksdream 6 months ago
SYK new 52 week high
👍️0
Monksdream Monksdream 6 months ago
SYK new 52 week high
👍️0
LORTAP KCOTS LORTAP KCOTS 8 months ago
Thank you SYK..
Another $52,000 profit in a quick 1 month flip.
👍️0
LORTAP KCOTS LORTAP KCOTS 2 years ago
Gonna get another 1000 shares on Monday
👍️0
LORTAP KCOTS LORTAP KCOTS 2 years ago
Bought a ton at $250
👍️0
LORTAP KCOTS LORTAP KCOTS 2 years ago
Started buying in at $257.25.
Getting some $255 shares today as well.
👍️0
LORTAP KCOTS LORTAP KCOTS 2 years ago
Gonna put in buy orders at $239, stupid markets about to roll over and this will be a safe entrance
👍️0
larry77 larry77 2 years ago
has everyone gone to sleep on this? WTF?
👍️0
LORTAP KCOTS LORTAP KCOTS 2 years ago
Sold 272.12, waiting to reload at $245
Made $33,000 last trade.
👍️0
LORTAP KCOTS LORTAP KCOTS 2 years ago
Got filled 249 today, ready sell orders to unload at 269 again..
👍️0
LORTAP KCOTS LORTAP KCOTS 2 years ago
Made $13,000 on SYK trade.
Reloading at $250
👍️0
LORTAP KCOTS LORTAP KCOTS 3 years ago
Picked up 1000 shares@258.50, let’s roll this into some bank at $278.50!!!
👍️0
LORTAP KCOTS LORTAP KCOTS 4 years ago
Murder on the wall street this week
👍️0
LORTAP KCOTS LORTAP KCOTS 4 years ago
Crushed today.
👍️0
flyonthewall flyonthewall 5 years ago
I agree bro. Check out SECI only 306,000 shares exist and a multi billion settlement deadline is scheduled by the Judge for February 7, 2020 otherwise Trial starts in May of 2020. Literally Billions on the line here. Just a 1 Billion Dollar Judgement or Settlement would create 1 share with an approximate Value of $3,200. A perfect storm is happening here for a massive payout on technology that was stolen and intended to save FireFighters lives giving us real time GPS Tracking and VoIP Communications.
👍️0
LORTAP KCOTS LORTAP KCOTS 5 years ago
The best secret stock to keep long term
👍️0
flyonthewall flyonthewall 5 years ago
Good to know. Yes that is also what I figured. This company produces amazing medical devices that there will always be a demand for in the Emergency Medical Services sector.
👍️0
Striker77 Striker77 5 years ago
Its always a great hold. Worth at least 220 right now. Only down because some didnt like the acquisition last week.
👍️0
flyonthewall flyonthewall 5 years ago
SYK going higher from here longs ? I have December 210 calls. Anyone have ideas on how SYK should do on this upcoming earnings ?
👍️0
LORTAP KCOTS LORTAP KCOTS 5 years ago
Sold a trading position at $210.50, will buy back at $192.50
That’s the plan, as I bought the shares at $175, 3 months ago.
👍️0
pontiacg6 pontiacg6 5 years ago
Former MAKO CEO JOINS TITAN MEDICAL - TICKER TMDI

https://apple.news/AgYXFxFsEROmMHtrBEJGGFQ

MAKO GOT BOUGHT BY STRYKER MAYBE TMDI NEXT
👍️0
LORTAP KCOTS LORTAP KCOTS 5 years ago
Boom another all time high!
👍️0
LORTAP KCOTS LORTAP KCOTS 5 years ago
All time high again
👍️0
PennyStock Alert PennyStock Alert 5 years ago
Almost all time high
👍️0
PennyStock Alert PennyStock Alert 5 years ago
YIELD GROWTH Announces Healthy Planet Canada, an Independent Health and Wellness Company with 24 Ontario Retail Locations
👍️0
PennyStock Alert PennyStock Alert 5 years ago
Stryker acquires Arrinex

Source: GlobeNewswire Inc.

Stryker (NYSE:SYK) announced today it has completed the acquisition of Arrinex, Inc., a medical device company headquartered in Menlo Park, California, that has developed ClariFix®, a novel cryoablation technology for the treatment of chronic rhinitis. This condition, which affects over 24 million people in the U.S. each year, may cause runny nose, congestion, sneezing and nasal itching. Arrinex, which was founded in 2013, began commercializing ClariFix in late 2017 in the U.S. ClariFix further expands Stryker’s Ear, Nose and Throat (ENT) portfolio with a unique product to address a large, underpenetrated segment of the ENT market where Stryker does not currently compete.
“The acquisition of Arrinex is highly complementary to Stryker’s ENT portfolio, which is part of our Neurotechnology business,” said Spencer Stiles, Stryker’s Group President, Neurotechnology, Instruments and Spine. “This acquisition aligns with our focus on providing ENT physicians with new technologies that deliver more treatment options and better patient outcomes.”

Forward-looking statements
👍️0
PennyStock Alert PennyStock Alert 5 years ago
Small dip
👍️0
LORTAP KCOTS LORTAP KCOTS 5 years ago
Another all time high!
👍️0
LORTAP KCOTS LORTAP KCOTS 5 years ago
And another one
👍️0
LORTAP KCOTS LORTAP KCOTS 5 years ago
New 52 week high!
👍️0
LORTAP KCOTS LORTAP KCOTS 5 years ago
Awesome day!
👍️0
LORTAP KCOTS LORTAP KCOTS 6 years ago
New 52 week highs
👍️0
LORTAP KCOTS LORTAP KCOTS 7 years ago
Up $11 boom
👍️0
LORTAP KCOTS LORTAP KCOTS 7 years ago
Got a bunch of shares yesterday for cheap..!
Now those will be up $10 in the next week.
👍️0
LORTAP KCOTS LORTAP KCOTS 7 years ago
New all time high
👍️0
stealthways stealthways 7 years ago
think Stryker has been very complacent about emerging tech ,mainly due to its leading strength in the Ortho segment (this is not uncommon in various industries and the skeletons of similarly over confident companies are littered) --- and has failed to see how significant the dangers are of transformational tech. The bashers of the AMDA stock, don't kid yourself, has also affected the Stryker over confidence with their own tech.. "Asleep at the switch" comes to mind....

Lets assume that Stryker, for what ever reason, "wakes up", from its tech hibernation, and see that AMDA is cleaning the books, auditing assets etc, and other hallmarks of a potential sale. Lets further assume, they understand how AMDA tech would likely help Zimmer take many Billions of their revenue away over the next 5 to 10 years and add incremental new revenue, from new sources, to Zimmer..
If you look at Strykers history, it looks to me to have more experience than Zimmer at growing by acquisition ... Even if Stryker has some kind of relationship with Zimmer currently likely this would be superficial. Anyways, based on these assumptions, why would Stryker sit back and let this deal happen with no interference (i.e. competing bid) from it .... even if they know of the personal connections between AMDA and Zimmer. So for example lets says Stryker calculates an AMDA sale to Zimmer would take $5 Billion off the Present Value (roughly equal to market cap) of Stryker.. and lets say Zimmer trys to low ball a $100 million bid for AMDA... Under this scenario, no matter what relationships are, it would make no sense for Stryker to just sit back and let this deal happen with no response. Even if Stryker thinks Zimmer may potentially outbid them , its better for Stryker to have Zimmer pay up at least , if they do succeed.

Bottom line is Stryker needs to wake up to emerging tech and protect their future by trying to own the tech at AMDA....The bashing and manipulation of AMDA hides the true value, and danger if in the hand of a competitor, of the technology..time is of the essence...
👍️0
stealthways stealthways 7 years ago
Amedica books have been recently getting cleaned up and assets audited at Amedica, prepping for a sale, so Stryker could be successful in a quick purchase of Amedica. Japan approval is coming and China is ready also... Lobo needs to give this a priority in Business Development..
👍️0
stealthways stealthways 7 years ago
Lobo needs to act quick ....Stryker has a chance to acquire Amedica and its tech before Zimmer Biomet. If Stryker, drops the ball, and allows Zimmer to get Amedica, with world wide patents for its new SiNi, 3-D printing tech, main asian markets near approval, anti-infective properties, and many more advantages, Zimmer will be a tough night in Hip-knee, and gain share in spine .... It is simple for Stryker to block Zimmer, if they act quick.... Zimmer is preparing now to acquire this tech but Stryker , by using its superior M&A skills can be quicker and block this threat ....
👍️0
ValueInvestor15 ValueInvestor15 8 years ago
SunTrust started Stryker $SYK at buy today. This 5-year EBITDA exit DCF analysis shows +25% upside: DCF

Buy?

👍️0
jimbob4stocks jimbob4stocks 8 years ago
Loaded up on this one back in 2012 in my 401k. Very impressed with it! Lots of upside
👍️0
EmptyBones EmptyBones 8 years ago
I think that little guy in your picture is unpredictable. Too funny.
👍️0

Your Recent History

Delayed Upgrade Clock